2. Joint National Committee on
Prevention, Detection,
Evaluation, & Treatment of
High Blood Pressure (JNC)
JNC 7: 2003
JNC 6: 1997
JNC 5: 1992
JNC 4: 1988
JNC 3: 1984
JNC 2: 1980
JNC 1: 1976
Detection, Evaluation,
&Treatment of High Blood
Cholesterol in Adults (ATP,
Adult Treatment Panel)
ATP III Update: 2004
ATP III: 2002
ATP II: 1993
ATP I: 1988
Clinical Guidelines on the
Identification, Evaluation, &
Treatment of Overweight and
Obesity in Adults
Obesity 1: 1998
5
5
History of NHLBI CVD Adult Clinical Guidelines
3. Điều trị THA
• WHO-ISH : 1998-2003
-THA là bệnh toàn cầu
-Trong 167 nước khảo sát ,61% không có hướng dẫn ĐT quốc
gia
- Mục tiêu của hướng dẫn
Đánh giá nguy cơ tim mạch toàn thể
Ngưỡng cần điều trị và mục tiêu điều trị
Điều trị dùng thuốc và không dùng thuốc
Chi phí và hiệu quả điều trị
• ESC-ESH : 2003-2007-2013
- Sử dụng khuyến cáo WHO-ISH
- Phân độ như JNC VI
- Mô hình SCORE
• VIỆT NAM
- Phân hội THA Việt Nam 2008 - 2014
- Bộ Y Tế Việt Nam 2010
• Hiện nay : ESC 2013 VA JNC 2014
Đồng thuận trong hướng dẫn điều trị THA
11. 035 140 530
12
0 : No tobacco
3 : walk 3km daily or 30 min
5 : proportion of fruit and vegetables a day
140 : blood pressure less than 140mmHg systolic
5 : total cholesterol < 5mmol/L
3 : LDLc < 3mmol/L
0 : Avoidance of overweight and diabetes
WWW: escordio.org
Education
12. Sinh beänh hoïc THA
CÔ CHEÁ TÖÏ ÑIEÀU HOØA
HUYEÁT AÙP =
Taêng Huyeát AÙp =
CUNG LÖÔÏNG TIM X SÖÙC CAÛN NGOAÏI BIEÂN
Taêng cung löôïng tim vaø/hoaëc Taêng söùc caûn ngoaïi
bieân
TIEÀN TAÛI CO BOÙP
CÔ TIM
CO THAÉT
CHÖÙC NAÊNG
THAY ÑOÅI CAÁU
TRUÙC (PHÌ ÑAÏI )
KHOÁI
LÖÔÏNG DÒCH
TAÙI PHAÂN PHOÁI
KHOÁI LÖÔÏNG DÒCH
TAÊNG HOAÏT TÍNH
TK GIAO CAÛM
HOAÏT TÍNH HEÄ RENIN-
ANGIOTENSIN
UCMC-UCTT AIIÖÙC
CHEÁ
LÔÏI TIEÅU
ÖÙC CHEÁ
Ca++
39. *Preferable BP goal for patients with renal disease with proteinuria >1 gm/24 h is <125/75 mmHg. †Initiate
monotherapy at the recommended starting dose with an agent from any of the following classes: diuretics, -
blockers, CCBs, ACEIs, or ARBs. ‡To achieve BP goals more expeditiously, initiate low-dose combination therapy
with any of the following combinations: -blocker/diuretic, ACEI/diuretic, ACEI inhibitor/CCB, or ARB/diuretic.
§Consider specific clinical indications when selecting agents.
Patient with elevated BP
If BP <145/90 mmHg,
monotherapy or
combination therapy
including a RAS blocker§
If BP 145/90 mmHg,
combination therapy
including a RAS blocker§
Add a 2nd agent from a
different class or
increase dose
Increase dose
or add a 3rd agent
from a different class
Diabetes/nondiabetic renal disease with
proteinuria >1 g/24 h*
Goal BP: <130/80 mmHg
Not at BP goal?
Intensify lifestyle changes AND
Add a 2nd agent from a
different class or
increase dose
If BP 155/100 mmHg,
combination therapy‡
If BP <155/100 mmHg,
monotherapy†
Increase dose
or add a 3rd agent
from a different class
Uncomplicated hypertension
Goal BP: <140/90 mmHg
Not at BP goal?
Intensify lifestyle changes AND
ISHIB Consensus Statement:
Management of Hypertension in African
Americans
Douglas JG et al. Arch Intern Med. 2003;163:525–541